Physician profile
Sandy George
NPI 1871643999
$1,075.90
in general payments reported to CMS, 2019-2025
17 companies · $77.44 in 2025
The $77.44 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $65.50 · 2021: $258 · 2022: $44.98 · 2023: $114 · 2024: $139 · 2025: $77.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $413.81 | 2019-2025 | Grafix, Collagenase Santyl, Pico 7 |
| Organogenesis INC. | $152.14 | 2019-2023 | Puraply |
| Sunovion Pharmaceuticals INC. | $103.49 | 2019 | |
| Glaxosmithkline, LLC. | $89.71 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.05 | 2021-2025 | Relistor, Xifaxan |
| Kerecis Limited | $50.19 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Kci USA, INC. | $34.54 | 2019 | |
| Melinta Therapeutics, LLC | $31.79 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $26.94 | 2022 | |
| Osiris Therapeutics INC. | $19.71 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $17.55 | 2021 | |
| Mimedx Group, INC. | $16.95 | 2025 | |
| Integra Lifesciences Corporation | $15.30 | 2020 | |
| Convatec INC. | $15.00 | 2019 | |
| Sumitomo Pharma America, INC. | $13.95 | 2025 | Gemtesa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $12.55 | 2019 | |
| Tactile Systems Technology INC | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandy George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.